A multi-institutional research initiative co-led by the University of Arizona College of Medicine – Tucson has uncovered definitive evidence that…
Read More
OrsoBio’s LXR Inverse Agonist Shows Promise for Hard-to-Treat Triglyceride Disorders, Paving New Path Beyond GLP-1 Dominance
OrsoBio, a specialized biotechnology firm dedicated to pioneering therapies for obesity and its associated metabolic conditions, is strategically charting a…
Read More
Gene Therapy Breakthrough Offers Non-Addictive Path for Chronic Pain Treatment via Brain-Specific Circuit Targeting
A groundbreaking preclinical study has identified a novel gene therapy that directly targets pain-processing regions within the brain, potentially revolutionizing…
Read More
Executive War College 2026 Speaker Spotlight Illuminates Path for Labs Navigating Reimbursement Pressures and Regulatory Shifts
The 2026 Executive War College on Diagnostics, Clinical Laboratory, and Pathology Management, scheduled for April 28-29 in New Orleans, is…
Read More
